Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daxxify
Pharma
Revance is being bought up by Crown Laboratories for $924M
After treading the commercial path alone for more than a year, Revance, maker of Botox rival Daxxify, has agreed to fly the Crown Laboratories flag.
Fraiser Kansteiner
Aug 12, 2024 2:45pm
Hoping to challenge AbbVie's Botox, Revance cuts Daxxify's price
Sep 20, 2023 8:40am
AbbVie's Botox aces phase 3 study in another cosmetic use
Sep 18, 2023 3:05pm
Revance's Daxxify scores first FDA approval for therapeutic use
Aug 14, 2023 2:16pm
Revance wants you to 'Break Up With Botox' in new AbbVie battle
Jun 29, 2023 9:25am
In cosmetic treatment battle, AbbVie sues Revance—again
May 3, 2023 3:04pm
